TransMedics Announces Impressive Q4 and Full Year 2025 Financial Performance and Growth Plans TransMedics Group, Inc. reports significant financial growth for Q4 and full year 2025. The company outlines future growth strategies aiming to enhance organ transplant therapies.

TransMedics Announces Impressive Q4 and Full Year 2025 Financial Performance and Growth Plans #United_States #TransMedics #Andover #organ_transplant #OCS_NOP